# SBRT in HCC With Oligoprogression on First-line Immunotherapy

> **NCT06434480** · NA · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- HCC

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy (SBRT)

## Key facts

- **NCT ID:** NCT06434480
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-21
- **Primary completion:** 2027-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06434480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06434480, "SBRT in HCC With Oligoprogression on First-line Immunotherapy". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06434480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*